BUSFAN

Busfan 60mg Injection is a chemotherapy drug classified as an anti-cancer (antineoplastic/cytotoxic) agent. It is an alkyl sulfonate that falls under the category of alkylating agents. This injection is used to treat chronic myelogenous leukaemia, a type of cancer characterized by an increase in white blood cells, and is administered as part of a conditioning regimen prior to hematopoietic progenitor cell transplantation, a procedure where a patient receives healthy blood-forming cells (stem cells) from a donor to replace their own stem cells that have been damaged by radiation or high doses of chemotherapy.

Chronic myelogenous leukaemia is a rare form of cancer that impacts the bone marrow, which is the soft, spongy tissue responsible for producing blood cells in the body. This condition leads to an elevated white blood cell count. The term “chronic” signifies that the disease progresses slowly and persists over an extended period. The term “Myelogenous” refers to the specific type of blood cells that are affected. This condition primarily occurs in older adults and is rarely seen in children, although it can affect individuals of any age.

Busfan 60mg Injections may lead to a significant reduction in bone marrow function. If you are currently taking other medications that lower blood cell counts, it is important to consult your healthcare provider before starting this treatment.